The Basis and Implications of Genetic Counseling in Patient Testing Choice by Tovpeko, Yanina
Syracuse University 
SURFACE 
Syracuse University Honors Program Capstone 
Projects 
Syracuse University Honors Program Capstone 
Projects 
Spring 5-1-2011 
The Basis and Implications of Genetic Counseling in Patient 
Testing Choice 
Yanina Tovpeko 
Follow this and additional works at: https://surface.syr.edu/honors_capstone 
 Part of the Biology Commons, Genetics Commons, and the Other Genetics and Genomics Commons 
Recommended Citation 
Tovpeko, Yanina, "The Basis and Implications of Genetic Counseling in Patient Testing Choice" (2011). 
Syracuse University Honors Program Capstone Projects. 259. 
https://surface.syr.edu/honors_capstone/259 
This Honors Capstone Project is brought to you for free and open access by the Syracuse University Honors Program 
Capstone Projects at SURFACE. It has been accepted for inclusion in Syracuse University Honors Program Capstone 
Projects by an authorized administrator of SURFACE. For more information, please contact surface@syr.edu. 
   
The Basis and Implications of Genetic 
Counseling in Patient Testing Choice 
 
 
A Capstone Project Submitted in Partial Fulfillment of the 
Requirements of the Renée Crown University Honors 






Candidate for B.S. in Biology 










 Honors Capstone Project in: _______Biology_________ 
 
Capstone Project Advisor: ______________________ 
Dr. Robert Roger Lebel 
 
Honors Reader: ______________________ 




Honors Director: ______________________ 
James Spencer, Interim Director 
 
Date: ______________________ 




Perinatal genetic counseling is a health service provided to patients 
who carry risk factors for genetic abnormalities for their offspring. There are 
several non-invasive and invasive tests offered to patients in order to provide 
genetic information about possible disorders. The non-invasive screens 
calculate a percentage of risk relative to average population risk. If the non-
invasive screens predict an elevated risk, a more invasive test can be offered 
to obtain definitive results about possible disorders in the pregnancy. The 
most commonly used invasive test is called amniocentesis and it carries a risk 
for pregnancy complications. After receiving abnormal results on the non-
invasive screens, patients have the option to continue with invasive testing to 
obtain definitive results.  
This project sought to discern factors predictive of testing choice after 
abnormal screen results. From 134 patient charts that fit certain criteria, 
several factors such as screen-calculated risk were analyzed and evaluated 
using a statistical analysis program.  
Of the factors analyzed, a trend in the data can be seen. The higher a 
woman’s calculated risk of genetic abnormality in the fetus, the more likely 
she was to continue onto invasive testing.  
This research has future implications for the field of genetic 
counseling. The more information there is concerning testing implications and 
testing choice, the better the care that health professionals will be able to 
provide.  
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The Basis and Implications of Genetic Counseling in Patient Testing Choice 
 
Introduction 
 Genetic counseling can be defined as a “process in which a genetic 
counselor educates families or individuals about their risk of passing on a 
genetic predisposition for certain disorders to future generations” (National 
Society of Genetic Counselors 2011). To achieve this goal, a genetic 
counselor will explain and discuss the patient’s current medical situation with 
the patient in order to inform and educate. During this counseling, the patients 
will be presented with the medical facts as well as a possible diagnosis. They 
will be taken through the likely progression of the disorder as well as possible 
treatments or cures.  Another goal of the genetic counseling session is for the 
patient to understand the inheritance of their possible affliction and how their 
medical history has contributed to the possible occurrence. With clear 
explanation of this information, the genetic counselor will also provide future 
options, such as testing and screens or support and referrals to other 
specialists. Overall, the goal of the genetic counselor is to inform the patients 
of how genetic history can affect medical future. 
Although genetic counseling can be provided to any patient for any 
medical situation, genetic counseling is especially commonly offered to 
pregnant women. There are many medical factors that might cause a woman 
to have a “high-risk pregnancy,” and if she does, she will likely be referred to 
a genetic counselor. The possible factors that can denote a possible high-risk 
   
pregnancy are many, each with a medical basis that might affect the 
pregnancy adversely. The first is “advanced maternal age”, where the mother 
will be 35 years or more at the age of delivery. This is a contributor to a high-
risk pregnancy, as many studies have shown that women over 35 have “an 
increase in intercurrent illness and pregnancy complications” (Jacobsson, 
Ladfors, and Milsom 2004).  
Women over the age of 35 also have “an increased risk for miscarriage 
and for chromosomal abnormalities…and fetal/neonatal congenital 
anomalies” (Cleary-Goldman et al. 2005). As the mother ages, so do the 
viable cells that might be fertilized to produce a pregnancy. This aging in cells 
is related to cellular division, and cells that do not divide properly may result 
in chromosomal nondisjunction (Dailey et al. 1996). The normal number of 
chromosomes in a human is 46: 23 from the mother and 23 from the father. 
During meiosis, germ cells divide from these 46 chromosomes to haploid cells 
containing 23 chromosomes, and at fertilization, return to the diploid state of 
46 chromosomes. If one chromosome pair does not divide properly, this 
results in nondisjunction, and the fetus resulting from fertilization will have an 
abnormal number of chromosomes. This abnormal number typically means 
that the fetus will have three or only one of a certain chromosome instead of 
two, and this results in fetal disorders, which denote a high-risk pregnancy. 
Another factor indicative of a high-risk pregnancy is fetal 
abnormalities that might be observed on an ultrasound. “Routine ultrasound 
screening…has the potential advantage of detecting most major fetal 
   
malformations” (Milunsky 2004). If such an anomaly is noted, a woman will 
be referred to a genetic counselor because of the high congruency of fetal 
abnormalities and genetic disease. 
Previous pregnancy complications of the patient or the patient’s family 
can be indicative of a future high-risk pregnancy. If a woman has had one or 
more miscarriages or stillbirth or neonatal death in a previous pregnancy, this 
will be a cause for concern, and lead to a referral to a genetic counselor. Also, 
if there is a clear indication in the patient’s family medical history of a 
heritable genetic disorder, this will raise alarm in the possibility of a high-risk 
pregnancy with this same genetic disorder. Similarly, if there is a family 
history of structural anomalies, again there may be potential for a high-risk 
pregnancy. If the family medical history contains individuals that have 
presented with neural tube defects, congenital heart defects, or cleft lip and 
palate, there is potential for recurrence in a future pregnancy, indicating the 
need for discussion of risk with a genetic counselor. 
Consultation is also recommended to the patient if the patient has an 
ethnic background with a disorder that occurs more commonly than in the 
general population. Examples of this include cystic fibrosis in Europeans, 
Tay-Sachs disease in Orthodox Jews and Eastern Europeans, and sickle-cell 
anemia in African Americans. If the patient is a member of such an ethnic 
group, a referral to a genetic counselor is recommended in that there can be 
prenatal diagnosis of a disorder or carrier testing for early detection of the 
disorder. A less likely family-related risk factor is consanguinity, where the 
   
parents are related, for example if the parents are first cousins. Consanguinity 
produces an increased risk of fetal disorders, because the parents may both 
carry the same defective gene and can pass it on to the fetus. If the pregnancy 
is the result of a consanguineous union, then genetic counseling is 
recommended. Moreover, there are many other less common factors that 
might indicate high-risk pregnancies such as history of or suspected 
metabolism abnormality, history of or suspected chromosomal rearrangement, 
or a family history of mental retardation or developmental disabilities. 
Currently it is routine to offer pregnant women serum screens that can 
test the mother’s blood for indicators of abnormalities in the pregnancy. 
Abnormal maternal serum marker screening results will cause a woman to be 
referred to a genetic counselor for discussion of risk in the pregnancy. After 
an abnormal result and consultation with the genetic counselor, the patient has 
the option to continue on to more invasive testing. Although there are many 
maternal serum marker screens, two of the most common are the Maternal 
Serum Alpha-Fetoprotein (MSAFP) and the Triple Screen. 
The MSAFP test is a blood test that evaluates the levels of alpha-
protein in the mother’s serum. This test is usually given between the 14th and 
22nd weeks of pregnancy. The test recognizes abnormal levels of alpha-
fetoprotein relative to a normal range and out-of-range values can predict the 
risk of a disorder in the fetus. This test has utility as a single analyte screen 
because if the alpha-fetoprotein level is high relative to the normal, this can 
   
indicate the possible presence of a neural tube defect. Conversely, low levels 
of alpha-fetoprotein can indicate Down Syndrome. 
The Triple Screen expands analysis from the MSAFP and measures 
two other analytes. This screen is primarily given to women who are between 
their 15th and 21st week of pregnancy, where it evaluates the levels of three 
analytes from the placenta and the fetus in order to predict elevated risk for 
the following fetal abnormalities; Down Syndrome (Trisomy 21), Edwards 
Syndrome (Trisomy 18), and Neural Tube Defects (NTD). Alpha-fetoprotein 
(AFP) is found in amniotic fluid and abnormal levels of this may indicate the 
presence of a fetal disorder. Human chorionic gonadotopin (hCG) is a protein 
produced by the placenta. Unconjugated estriol (uE3) is made in the fetus and 
placenta. Based on extensive studies of levels of these hormones, a prediction 
can be made as to the possible abnormality in a fetus. The screen can detect 
“Down Syndrome in 69% of cases and…neural tube defects in 80% of the 
cases” (American College of Obstetrics and Gynecology 2007). If the levels 
of all three analytes are low, this is an indication for Trisomy 18. Also, the test 
is dependant on the predicted age of the fetus, so an incorrectly assessed age 
could result in perceived abnormal protein levels.   
 It is a common misconception that, since these screens do not detect 
all cases of fetal abnormalities, these screens are not accurate. The screens 
accurately test analyte levels and return a calculated risk. Also, an elevated 
calculated risk does not absolutely mean that there is an abnormality in the 
fetus. The elevated calculated risk is the analyte level relative to baseline 
   
population risk. Although they do not detect all cases of fetal abnormalities, 
their ability to detect possible fetal disorders makes them very useful to 
prenatal genetic screening. 
 Once either of these screens has established an abnormal level of 
analytes, possibly indicating a disorder in the fetus, the patient has the option 
to continue on to an ultrasound or a more invasive form of testing. Ultrasound 
uses sound waves to visualize the fetus and its body structures. Ultrasound is 
non-invasive and commonly used to detect abnormalities that have physical 
manifestations. Also, ultrasound allows for “the detection of not only major 
malformations but also subtle markers of chromosomal abnormalities and 
genetic syndromes” (Milunsky 2004). For example, fetuses with Down 
Syndrome often have thick skin at the posterior section of the neck (nuchal 
fold) and the size of this can be measured on an ultrasound. This procedure 
assists in diagnosis of possible genetic disorders in the fetus. 
 The most common invasive test performed in this situation is 
amniocentesis. Amniocentesis is considered invasive because the test entails 
the use of a needle to enter the amniotic sac and withdraw approximately 15 – 
30 mL of amniotic fluid for testing. Under ultrasound guidance, the physician 
will find the precise location of the fetus, and point the needle towards an area 
of the amniotic sac that only contains fluid. Then the fluid is extracted and the 
needle is removed. The entire procedure takes about two minutes. The 
amniotic fluid that is withdrawn carries valuable information about the fetus, 
including the possible occurrence of Down Syndrome. Also, the test provides 
   
a full karyotype of the chromosomes of the fetus, enabling chromosomal 
studies and prediction of possible genetic disorders. Although this test 
provides extremely useful diagnostic information, it carries risk factors for the 
pregnancy because of its invasive nature. These risk factors “can include 
rupture of the membranes and subsequent miscarriage” (Sloane 144). The 
estimated increase risk of miscarriage as a result of amniocentesis is 
approximately 0.2% (R. Lebel, personal communication). As amniocentesis 
carries the risk of pregnancy complications, the decision to continue from 
non-invasive to invasive testing is one that often takes much consideration on 
the part of the patient. 
 This decision to move from non-invasive testing to more definitive 
invasive testing in the case of a pregnancy with genetic disorder risk is one 
that entails many different factors. The various factors that might affect this 
decision are of particular interest to me, in that they may be predictive of 
testing choice and they can show the effect of testing on patient choice. While 
the actual factors that can affect this decision are numerous, the ones that are 
readily evaluated are age of the patient, the patient’s population risk for a 
disorder of the fetus, the MSAFP or Triple Screen screen-calculated risk, and 
whether previous children of the patient have genetic disorders. Another 
factor that might affect the decision to continue onto invasive testing is the 
income of the patient. There is a high correlation between income and 
education level (Day & Newburger 2002). Income is often an indicator of 
education level, and education level is often an indicator of the patient’s 
   
ability to perceive statistics and calculated risk. As each of these affects 
patient outlook, they may influence a patient’s choice to continue with 
invasive testing after a non-invasive screen produces abnormal results. 
 
Methods and Materials 
 In order to conduct a study that evaluates the possible factors that 
might affect patient testing decisions, subjects that fit certain criteria were 
obtained. Dr. Robert Roger Lebel provided his patient files that ranged from 
1997 to 2003.  Because they had reached the statutory limit for medical 
records after closing of a physician’s practice, these charts were all in the 
process of being destroyed.  This rendered them beyond any possible contact 
to the patients, and thus satisfied the criteria of the Institutional Review Board 
of the SUNY Upstate Medical University, to allow use of identifying 
information. The protocol was approved. 
 These patients were seen in Dr. Lebel’s practice in Glen Ellyn, Illinois. 
From these patients, I selected those that fit specific criteria. Patients had 
elected to have either the Triple Screen or MSAFP test performed by their 
obstetricians. After having the test performed, they received an abnormal 
result and were referred to Dr. Lebel to discuss their result. After they had the 
consultation, they made the decision whether to have no more procedures at 
all, an ultrasound only, or ultrasound with amniocentesis. From the patient 
charts that fit these criteria, I recorded additional information on a sheet 
specific to each chart. I recorded the patient’s age at delivery and the 
   
population risk that was told to the patient. Dr. Lebel told the population risk 
to the patient as based on Hook 1981. This value was given as a number 
denoting the possible occurrence of a genetic disorder at that age out of 1000 
women of that age. I also recorded the patient’s decision after the discussion 
of their screen result. I recorded the result of the ultrasound if the patient 
chose to have one as well as the result of the amniocentesis if the patient 
chose to have one. Also I recorded the screen-calculated risk, given as 1 out of 
denominator, denoting the chance of a genetic disorder occurring in the fetus 
relative to baseline population risks for pregnant women of that age. I 
recorded whether the women had children previous to the pregnancy in 
question, and whether those children were healthy or not. Also recorded were 
the patient’s marital status, previous miscarriages, a family history of genetic 
disorders, a family history of miscarriage or stillbirth, and the patient’s 
ethnicity but preliminary analysis did not yield any results with statistical 
significance. 
 In total, 134 charts fit the selection criteria. Data were entered into a 
Microsoft Excel spreadsheet for the purpose of organization. Zip codes were 
used to estimate the median income of the patient’s neighborhood based on 
the 2000 Census data of average income (US Census Bureau 2000). The 
calculated risk and population risks were converted into percentages. For 
statistical analysis, IBM® SPSS® Statistics V. 18 was used. A one-way 
analysis of variance (ANOVA), was used to determine whether decision was 
affected by calculated risk or income. A chi-square analysis was done to 
   
determine whether decision to choose an invasive test was dependent on the 
presence of previous unhealthy children. A regression analysis was done to 




 Figure 1 is a graph of the population risk depending on the age of the 
patient at delivery. The data are based on Hook’s values as told to the patients. 
Hook’s data shows that women over the age of 35 are at higher risk of a 
chromosomal abnormality occurring in their pregnancy. Before the age of 35, 
the risk of a disorder in pregnancy is relatively low and has a very gradual 
slope of increase until the age of 35. However, after the age of 35, the slope 
and risk of disorder in pregnancy increased exponentially. This explains the 
concern for pregnancies in women who are older and supports genetic 
counseling as an option for women who have pregnancies later in life. The 
population risk is calculated as a percentage, such as 0.1% chance of 





   
 
 Figure 2 depicts the distribution of patients making each possible 
decision. Out of 134 patients, 12 patients made the decision to not continue to 
any procedure at all and this is denoted by decision = 0. Twenty-nine patients 
made the decision to have ultrasound only and this is denoted by decision = 1. 
Ninety-three patents made the decision to have both an amniocentesis and an 
ultrasound and this is denoted by decision = 2. This shows that 9% of the 
patients surveyed chose no procedure, 22% chose to have ultrasound only, and 
69% chose to have ultrasound and amniocentesis. Overall, 91% of the patients 
 
 
Figure 1. Population risk of chromosomal abnormalities in the 
fetus by age of the mother at delivery. These values are based on 
Hook’s data (Hook 1981). Population risk is given as a 
percentage, where .001 means 0.1% chance of an abnormality 
   
chose to have some procedure, whether it was ultrasound only or both 
ultrasound and amniocentesis. Of those who did chose to continue on to a 
procedure, 24% chose to have ultrasound only and 76% chose to have an 
ultrasound and amniocentesis. 
 
 Figure 3 shows the decision made when previous children were 
healthy versus unhealthy. Here, only those patients with previous children 
were considered. The plot shows that some patients made each decision option 
if their previous children were healthy. However, while the sample size is 
small, this also shows that none of the patients who had unhealthy children 
 
Figure 2. Graph of the number of decisions made in each 
decision category. 134 total patients, 12 chose no procedure 
(decision = 0). 29 chose ultrasound only (decision = 1). 93 
chose ultrasound and amniocentesis (decision = 2).   
 
   
chose to go without any procedure. This could indicate that the presence of a 
previously unhealthy child might influence the patient’s decision towards 
having some procedure rather than no procedure at all, but the chi-square test 
showed that these two factors were independent (X2=0.64; df=2; p=0.73).  
 
 Figure 4 is a scatter plot of the patient’s age versus the screen- 
calculated risk is defined by personal medical history. The calculated risk is 
calculated as a percentage, such as 0.1% chance of genetic abnormality in the 
fetus, which corresponds to a graph value of 0.01. There was no relationship 
 
Figure 3. Previous children healthy or not versus decision 
made. For previous children healthy 0=healthy, 1=at least 
one unhealthy child. For decision, 0=no procedure, 
1=ultrasound only, 2=ultrasound and amniocentesis. The 
numbers adjacent to the points indicate the number of 






   
between patient age and the calculated risk (F=0.008; df=1; p=0.929). 
Indicating that the two factors are independent of each other 
 
 Figure 5 shows the calculated risk versus the decisions made. 
Regardless of risk, most patients chose to have ultrasound with amniocentesis. 
Those who chose no procedure at all had lower risks, although these were not 
statistically significant (F=0.391; df=2; p=0.677). The calculated risk is 
calculated as a percentage, such as 0.1% chance of genetic abnormality in the 
fetus, which corresponds to a graph value of 0.01.  
 
Figure 4. Age v. calculated risk. Calculated risk is given as a 
percentage, where .01 means 1% chance of an abnormality 
occurring in the fetus. 
 
   
 Figure 6 is a scatter plot of average income of zip code versus decision 
made. In this analysis, income had no influence on the decision made by the 
patient (F=0.461; df=2, 131; p=0.631).  
 
 
Figure 5. Calculated risk v. decision made. For decision, 0=no 
procedure, 1=ultrasound only, 2=ultrasound and amniocentesis. 
Calculated risk is given as a percentage, where .01 means 1% chance 




Figure 7. Average income of each decision option. Income is in 
dollars. For decision, 0=no procedure, 1=ultrasound only, 
2=ultrasound and amniocentesis. 
   
 Figure 8 is the average calculated risk of each decision option. Of each 
decision option, the average calculated risk was calculated and plotted. The 
calculated risk is calculated as a percentage, such as 0.1% chance of genetic 
abnormality in the fetus, which corresponds to a graph value of 0.01. The 
results indicate that there are no significant differences in calculated risk for 
the three decision categories (F=0.391; df=2,113; p=0.677). Although the data 
are not statistically significant, a trend can be seen where those with lower 
percentages choose no procedure. A Power Test was done which indicated 




Figure 8. Average calculated risk of each decision. For decision, 
0=no procedure, 1=ultrasound only, 2=ultrasound and 
amniocentesis. Calculated risk is given as a percentage, where .01 
means 1% chance of an abnormality occurring in the fetus. 
   
Discussion  
The previous results were organized by the logical progression of 
questions asked about the data and they will be discussed here in the same 
order. The goal of the study was to examine the factors affecting patient 
choice of non-invasive screens versus invasive testing. Of the factors 
analyzed, the calculated risk is the best predictor of testing choice. The higher 
a woman’s calculated risk of genetic abnormality in the fetus, the more likely 
she was to continue onto invasive testing. This is especially interesting 
because it raises the question of understanding values of risk presented by a 
health professional.  
 Figure 1 is a graph based on Hook’s values of population risk of 
genetic disorders at a certain age. This supports the premise that as women 
increase in age, the risk of a chromosomal abnormality occurring in their 
pregnancy also increases. Before the age of 35, the risk of a disorder in 
pregnancy is relatively low and has a very gradual slope of increase until the 
age of 35. However, after the age of 35, the slope and risk of disorder in 
pregnancy increase exponentially. This explains the concern for pregnancies 
in women who are older and supports genetic counseling as an option for 
women who have pregnancies later in life. The data are a reference to 
compare population risk to screen calculated risk.  
 Figure 2 provided the number of decisions made in each category, 
whether it was no further procedures, ultrasound only, or amniocentesis and 
ultrasound. These data showed that most women chose to proceed on to at 
   
least some procedure rather than none. Also, the data show a three to one ratio 
of women who chose amniocentesis and ultrasound to ultrasound only. From 
this, it can be determined that women who are presented with an elevated risk 
are nine times more likely to chose some sort of procedure to obtain further 
information about their possible high risk pregnancy. This can be explained by 
a need for more information in the event of a possible complication in 
pregnancy.  
 There are also readily apparent ascertainment biases here. In order for 
a chart to qualify for selection, the patients first had to see an obstetrician and 
agree to have one of the prenatal screens. They had to return to their 
obstetrician to receiver the abnormal results and then agree to see a genetic 
counselor to discuss their results. Since all of these levels give the patient the 
option to eschew information, those who passed all these levels of selection 
clearly wanted information about their pregnancy. Therefore, they are already 
more likely to seek more information about their pregnancy in the form of 
another procedure, which explains the high occurrence of the choice to at least 
have an ultrasound after an abnormal result.  
 Figure 3 shows the analysis of whether having a previous child with a 
genetic abnormality influenced the choice of testing in the current pregnancy. 
Statistical analysis showed that the data were not statistically significant, but a 
trend can be seen. If the patients had previous children that were healthy, this 
did not influence testing choice. If the patients had previous children who 
were unhealthy, they chose at least some procedure. This also shows that none 
   
of the patients who had unhealthy children chose to go without any procedure. 
However, it should be noted that the sample size is small. This could indicate 
that the presence of a previously unhealthy child might influence the patient’s 
decision towards having some procedure rather than no procedure at all. The 
possibility of recurrence of a genetic abnormality seems to predict that women 
will chose to have at least some procedure to seek more information about 
their possible high risk pregnancy.  
 Figure 4 provided an analysis of a patient’s age and her screen 
calculated risk. The data were not statistically significant, so there was no 
clear correlation in the data. This indicates that calculated risk is dependant on 
personal medical history. This is interesting because population risk is 
influenced by age whereas calculated risk is not influenced by age. 
 Figure 5 shows the analysis of the screen-calculated risk and the 
decision made. Overall, these data show that most patients chose to have 
ultrasound and amniocentesis, which was observed previously as well. A trend 
can be seen where those with higher screen-calculated risks mostly chose at 
least an ultrasound over no procedure at all. However, since the data were not 
statistically significant, screen calculated risk does not affect the decision that 
is made. 
 Figures 6 and 7 examine whether income had an effect on the patient’s 
testing choice. This was analyzed because income is often a predictor of level 
or education, and level of education is often a predictor of a person’s ability to 
perceive statistics. Unfortunately, the education level of the patient was not 
   
available, so income had to be used as a best approximation. Income was not 
listed on the patient chart, so instead the median income of the patient’s zip 
code was used. The data were not statistically significant, so the analysis of 
the data did not clearly show that income influenced patient decision. This is 
understandable because the data for income were not as accurate as desired for 
each patient. In a future study, it might be interesting to consider the decision 
made in light of the patient’s education level, to see whether this had an effect 
on patient testing choice. 
 Figure 8 is support for the hypothesis that increased screen-calculated 
risk is a predictor of testing choice. A clear trend can be seen, where the 
higher a patient’s calculated risk, the more likely she was to choose to have a 
procedure that would provide more information about her possible high-risk 
pregnancy. Also, it is interesting to note the difference in the average risk of 
each choice. The average calculated risk of those who chose to not have any 
procedure is half of the average calculated risk of those who chose further 
procedures. However, the trend is not statistically significant at this sample 
size. 
 The influence of elevated calculated risk is interesting because it raises 
the question of patient understanding of values of risk presented by a genetic 
counselor. Further studies involving surveys of patient understanding of 
statistics and education levels would be helpful in furthering the 
understanding of factors that my influence patient testing choice. This 
research has future implications for the genetic counseling field. The more 
   
information there is concerning testing implications and testing choice, the 
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Genetic counseling can be defined as a “process in which a genetic 
counselor educates families or individuals about their risk of passing on a 
genetic predisposition for certain disorders to future generations” (“National 
Society of Genetic Counselors”). To achieve this goal, a genetic counselor 
will explain and discuss the patient’s current medical situation with the patient 
in order to inform and educate. During this counseling, the patients will be 
presented with the medical facts as well as a possible diagnosis. They will be 
taken through the likely progression of the disorder as well as possible 
treatments or cures.  Another goal of the genetic counseling session is for the 
patient to understand the inheritance of their possible affliction and how 
personal medical history has contributed to the possible occurrence. With 
clear explanation of this information, the genetic counselor will also provide 
options, such as testing and screens or support and referrals to other 
specialists. Overall, the goal of the genetic counselor is to inform patients of 
how genetic history can affect medical future. 
Although genetic counseling can ideally be provided to any patient for 
any medical situation, genetic counseling is especially commonly offered to 
pregnant women. There are many medical factors that might cause a woman 
to have a “high-risk pregnancy,” and if she does, she will likely be referred to 
a genetic counselor. The possible factors that can denote a possible high-risk 
pregnancy are many, each with a medical basis that might affect the 
pregnancy adversely.  
   
Currently it is routine to offer pregnant women serum screens that can 
test the mother’s blood for indicators of abnormalities in the pregnancy. 
Abnormal maternal serum marker screening results will cause a woman to be 
referred to a genetic counselor for discussion of risk in the pregnancy. After 
an abnormal result and consultation with a genetic counselor, the patient has 
the option to continue onto more invasive testing. Although there are many 
maternal serum marker screens, two of the most common are the Triple 
Screen and the Maternal Serum Alpha-Fetoprotein (MSAFP). 
 Once either of these screens has established an abnormal level of 
analytes, possibly indicating a disorder in the fetus, the patient has the option 
to continue on to an ultrasound or a more invasive form of testing. The most 
common invasive test performed in this situation is amniocentesis, which 
carries a low risk of pregnancy complications.  
 This decision to move from non-invasive testing to more definitive 
invasive testing in the case of a pregnancy with genetic disorder risk is one 
that probably entails many different factors. The various factors that might 
affect this decision are of particular interest to me, in that they may be 
predictive of testing choice and they can show the effect of testing on patient 
choice. While the actual factors that can affect this decision are numerous, the 
ones that can be evaluated are age of the patient, the patient’s population risk 
for a disorder of the fetus, the patient’s screen calculated risk of disorder in 
the fetus, previous children and whether those previous children are healthy or 
not. Marital status, previous miscarriages, a family history of genetic 
   
disorders, a family history of miscarriage or stillbirth, and the patient’s 
ethnicity were also extracted from the charts, but preliminary analysis did not 
yield any results with statistical significance. Another factor that might affect 
the decision to continue onto invasive testing is the income of the patient, as it 
might denote the education level of the patient and her ability to perceive 
statistics and calculated risk. As each of these affects the patient’s outlook, 
they can be factors that affect the patient’s choice to continue with invasive 
testing after a non-invasive screen produces abnormal results. 
 In order to conduct a study that evaluates the possible factors that 
might affect a patients testing decision, subjects that fit certain criteria were 
obtained. These patients were seen in Dr. Robert Roger Lebel’s practice in 
Glen Ellyn, Illinois. From these patients, I selected those that fit specific 
criteria. Patient records were available for women who elected to have one of 
the two screens and received consultation from a genetic counselor. 
Afterwards they had the option to have no further procedures, ultrasound only, 
or ultrasound with amniocentesis. The data was recorded and analyzed. 
 One of the limiting factors of the data used can be attributed to 
ascertainment bias. Since there are many levels of health professional visits 
that the patient must attend before the patient qualified for my criteria, these 
limiting factors must be discussed. In order for a chart to qualify for selection, 
the patients first had to see an obstetrician and agree to have one of the 
prenatal screens. They had to return to their obstetrician to receive the 
abnormal results and then agree to see a genetic counselor to discuss their 
   
results. Since all of these levels give the patient the option to eschew 
information, those who passed all these levels of selection clearly wanted 
information about their pregnancy. Therefore, they are already more likely to 
seek more information about their pregnancy in the form of another 
procedure, which explains the high occurrence of the choice to at least have an 
ultrasound after an abnormal result.  
Of the factors analyzed, a trend in the data can be seen. The higher a 
woman’s calculated risk of genetic abnormality in the fetus, the more likely 
she was to continue on to invasive testing. The average calculated risk of the 
choice to not have any procedure is approximately two times lower than the 
average calculated risk of the further procedure choices. This is especially 
interesting because it raises the question of understanding values of risk 
presented by a health professional. However, this trend is not statistically 
significant because of the small sample size.  
Further studies involving surveys of patient understanding of statistics 
and education levels would be helpful in furthering the understanding of 
factors that my influence patient testing choice. This research has future 
implications for the field of genetic counseling. The more information there is 
concerning testing implications and testing choice, the better the care that 
health professionals will be able to provide. 
 
